Sinn Féin - On Your Side

‘Trade agreements benefit Big Pharma, not patients’- Lynn Boylan MEP

7 August, 2015 - by Lynn Boylan MEP


Sinn Féin MEP and member of the European Parliament’s Environment and Public Health Committee Lynn Boylan today reacted to a leaked draft of the patents and pharmaceuticals section from the Trans-Pacific Partnership (TPP) –a trade agreement being negotiated between the US and 11 Pacific countries.

‘This leaked draft shows us exactly why we should be extremely wary of the trade agreement currently being negotiated between the US and Europe, TTIP.

‘Multinational drug companies have heavily lobbied governments to see elements included which will do everything for their business model and nothing for the citizens.

‘The US is lobbying for extremely long drug patents on behalf of its pharma companies at the expense of access to affordable life-saving drugs for the citizens of the countries involved in the trade agreement. Cheaper generic versions of drugs would be delayed from entering at the market, guaranteeing the drug companies’ monopolies in the market whilst denying ordinary patients access to much-needed medicine.

‘It is essential we reject trade agreements such as TPP or TTIP – they are nothing more than a fulfilment of corporate wish lists and must be stopped.’

Connect with Sinn Féin